BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Minalyan A, Gabrielyan L, Pietra C, Taché Y, Wang L. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats. Front Integr Neurosci 2019;13:13. [PMID: 31031602 DOI: 10.3389/fnint.2019.00013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Jones-Tabah J. Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease. J Mol Biol 2022;:167927. [PMID: 36563742 DOI: 10.1016/j.jmb.2022.167927] [Reference Citation Analysis]
2 Bispo JMM, Melo JEC, Gois AM, Medeiros KAAL, Silva RS, Leal PC, Franco HS, Souza MF, Lins LCRF, Ribeiro AM, Silva RH, Santos JR. Testosterone propionate improves motor alterations and dopaminergic damage in the reserpine-induced progressive model of Parkinson's disease. Brain Res Bull 2022;187:162-8. [PMID: 35781030 DOI: 10.1016/j.brainresbull.2022.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Oliynyk Z, Rudyk M, Svyatetska V, Dovbynchuk T, Tolstanova G, Skivka L; ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine;, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine;, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine;, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine;, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine;. Systemic inflammation biomarkers in 6-OHDA- and LPS-induced Parkinson’s disease in rats. Ukr Biochem J 2022;94:33-43. [DOI: 10.15407/ubj94.01.033] [Reference Citation Analysis]
4 Behl T, Madaan P, Sehgal A, Singh S, Makeen HA, Albratty M, Alhazmi HA, Meraya AM, Bungau S. Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective. Int J Mol Sci 2022;23:4565. [PMID: 35562956 DOI: 10.3390/ijms23094565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Amatya R, Min KA, Shin MC. A review of glucoregulatory hormones potentially applicable to the treatment of Alzheimer’s disease: mechanism and brain delivery. J Pharm Investig . [DOI: 10.1007/s40005-022-00566-y] [Reference Citation Analysis]
6 Giorgioni G, Del Bello F, Quaglia W, Botticelli L, Cifani C, Micioni Di Bonaventura E, Micioni Di Bonaventura MV, Piergentili A. Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor. J Med Chem 2022. [PMID: 35157454 DOI: 10.1021/acs.jmedchem.1c02191] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Liu M, Jiao Q, Du X, Bi M, Chen X, Jiang H. Potential Crosstalk Between Parkinson's Disease and Energy Metabolism. Aging Dis 2021;12:2003-15. [PMID: 34881082 DOI: 10.14336/AD.2021.0422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Gaggi G, Di Credico A, Izzicupo P, Iannetti G, Di Baldassarre A, Ghinassi B. Chemical and Biological Molecules Involved in Differentiation, Maturation, and Survival of Dopaminergic Neurons in Health and Parkinson's Disease: Physiological Aspects and Clinical Implications. Biomedicines 2021;9:754. [PMID: 34209807 DOI: 10.3390/biomedicines9070754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Nurrahma BA, Tsao SP, Wu CH, Yeh TH, Hsieh PS, Panunggal B, Huang HY. Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism. Front Aging Neurosci 2021;13:668775. [PMID: 34025392 DOI: 10.3389/fnagi.2021.668775] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
10 Menozzi E, Macnaughtan J, Schapira AHV. The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance. Ann Med 2021;53:611-25. [PMID: 33860738 DOI: 10.1080/07853890.2021.1890330] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
11 Zheng Y, Zhang L, Xie J, Shi L. The Emerging Role of Neuropeptides in Parkinson's Disease. Front Aging Neurosci 2021;13:646726. [PMID: 33762925 DOI: 10.3389/fnagi.2021.646726] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
12 Jhuo CF, Hsieh SK, Chen CJ, Chen WY, Tzen JTC. Teaghrelin Protects SH-SY5Y Cells against MPP+-Induced Neurotoxicity through Activation of AMPK/SIRT1/PGC-1α and ERK1/2 Pathways. Nutrients 2020;12:E3665. [PMID: 33260513 DOI: 10.3390/nu12123665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Alqaderi H, Tavares M, Al-Mulla F, Al-Ozairi E, Goodson JM. Late bedtime and dental caries incidence in Kuwaiti children: A longitudinal multilevel analysis. Community Dent Oral Epidemiol 2020;48:181-7. [PMID: 32077126 DOI: 10.1111/cdoe.12523] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]